J0200 — Injection, alatrofloxacin mesylate, 100 mg
J0200 is a HCPCS Level II code for injection, alatrofloxacin mesylate, 100 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J0200 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J0200
- Long descriptor
- Injection, alatrofloxacin mesylate, 100 mg
- Short descriptor
- Alatrofloxacin mesylate
- Added
- January 1, 2000
- Terminated
- December 31, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J0200
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0200 is not quite right, the correct code is very often within a few positions of it.
- J0175Injection, donanemab-azbt, 2 mg
- J0177Injection, aflibercept hd, 1 mg
- J0178Injection, aflibercept, 1 mg
- J0179Injection, brolucizumab-dbll, 1 mg
- J0180Injection, agalsidase beta, 1 mg
- J0184Injection, amisulpride, 1 mg
- J0185Injection, aprepitant, 1 mg
- J0190Injection, biperiden lactate, per 5 mgterminated
- J0202Injection, alemtuzumab, 1 mg
- J0205Injection, alglucerase, per 10 unitsterminated
- J0206Injection, allopurinol sodium, 1 mg
- J0207Injection, amifostine, 500 mg
- J0208Injection, sodium thiosulfate (pedmark), 100 mg
- J0209Injection, sodium thiosulfate (hope), 100 mg
- J0210Injection, methyldopate hcl, up to 250 mg
- J0211Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
Questions about J0200
What is HCPCS code J0200?
J0200 is a HCPCS Level II code for injection, alatrofloxacin mesylate, 100 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0200?
The CMS HCPCS file marks J0200 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J0200 still valid?
No. J0200 was terminated on December 31, 2025 and should not be used on new claims.